Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)

  1. Vukusic, S.
  2. Brassat, D.
  3. de Seze, J.
  4. Izquierdo, G.
  5. Lysandropoulos, A.
  6. Moll, W.
  7. Vanopdenbosch, L.
  8. Arque, M.J.
  9. Kertous, M.
  10. Rufi, P.
  11. Oreja-Guevara, C.
Zeitschrift:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356 2211-0348

Datum der Publikation: 2019

Ausgabe: 29

Seiten: 7-14

Art: Artikel

DOI: 10.1016/J.MSARD.2019.01.019 GOOGLE SCHOLAR